E83.825
CD73 deficiency causing arterial calcification
Clinical Classification Guidelines
Medical Intelligence & Overview
CD73 deficiency, associated with the ICD-10 code E83.825, is a rare genetic condition characterized by the improper regulation of calcium deposits in the arteries. This deficiency can lead to a build-up of calcium in the arterial walls, a process known as arterial calcification. The condition affects blood flow and can increase the risk of cardiovascular complications. Understanding the nature of CD73 deficiency and its impact on arterial health is important for diagnosis and management.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting the NT5E gene, which provides instructions for making the CD73 enzyme. Inheritance of faulty copies of the NT5E gene from parents, leading to decreased or absent enzyme activity. Environmental factors generally do not directly cause the deficiency, but can influence overall cardiovascular health. Potential interactions with other genetic or metabolic conditions that may exacerbate arterial calcification.
Key Symptoms: Progressive arterial stiffening and narrowing, often leading to reduced blood flow. Pain or discomfort in affected areas, especially during physical activity. Signs of peripheral artery disease, such as coldness or numbness in limbs. Possible skin changes or ulcers due to poor blood circulation. In some cases, there may be no noticeable symptoms until complications arise. Bone abnormalities or other related features may occasionally be observed.
Diagnostic & Treatment
Diagnosis Path: Diagnosing CD73 deficiency involves a combination of clinical evaluation, blood tests, and genetic analysis. Key steps include: - Measuring calcium and phosphate levels in the blood. - Imaging studies, such as ultrasound or CT scans, to assess arterial calcification. - Genetic testing to identify mutations in the NT5E gene. - Enzyme activity assays to evaluate CD73 function. Diagnosis aims to differentiate this condition from other causes of arterial calcification and to assess the extent of vascular involvement.
Treatment Protocols: There is currently no specific cure for CD73 deficiency. Management focuses on controlling symptoms and preventing complications: - Lifestyle modifications, such as adopting a heart-healthy diet and engaging in regular, gentle exercise. - Medications to improve blood flow or manage cardiovascular risk factors. - Monitoring for signs of arterial narrowing or blockages. - In some cases, surgical interventions or procedures might be necessary to restore blood flow. - Ongoing research aims to develop targeted therapies addressing the underlying enzyme deficiency. It is essential for individuals diagnosed with this condition to work closely with healthcare providers specializing in vascular and genetic disorders.
Clinical Advice & FAQs
Billing Guidance
Is E83.825 a billable ICD-10 code?
Yes, E83.825 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E83.825?
Clinical documentation must specify the nature of CD73 deficiency causing arterial calcification and any associated comorbidities for accurate reporting.
Cite this Clinical Reference